(NYSE: LLY) Eli Lilly & Co's forecast annual revenue growth rate of 19.85% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 8.46%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.76%.
Eli Lilly & Co's revenue in 2024 is $35,932,100,000.On average, 5 Wall Street analysts forecast LLY's revenue for 2024 to be $40,879,769,760,721, with the lowest LLY revenue forecast at $40,376,072,013,438, and the highest LLY revenue forecast at $41,968,947,638,752. On average, 7 Wall Street analysts forecast LLY's revenue for 2025 to be $49,697,942,664,996, with the lowest LLY revenue forecast at $46,950,026,068,400, and the highest LLY revenue forecast at $53,125,845,803,113.
In 2026, LLY is forecast to generate $58,785,790,246,332 in revenue, with the lowest revenue forecast at $55,511,277,785,488 and the highest revenue forecast at $64,320,537,788,053.